Your browser doesn't support javascript.
loading
Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
Chauffaille, Maria de Lourdes L. F; Zalcberg, Ilana; Barreto, Wolney Gois; Bendit, Israel.
Afiliación
  • Chauffaille, Maria de Lourdes L. F; Grupo Fleury. BR
  • Zalcberg, Ilana; Instituto Nacional do Cancer - INCA. Centro de Transplante de Medula Óssea. Rio de Janeiro. BR
  • Barreto, Wolney Gois; Hemocentro. BR
  • Bendit, Israel; Universidade de São Paulo - USP. Faculdade de Medicina. Hospital das Clínicas. BR
Hematol., Transfus. Cell Ther. (Impr.) ; 42(3): 261-268, July-Sept. 2020. tab
Artículo en Inglés | LILACS | ID: biblio-1134048
Biblioteca responsable: BR408.1
Ubicación: BR408.1
ABSTRACT
ABSTRACT Chronic lymphocytic leukemia is the most common hematologic malignancy among adults in Western countries. Several studies show that somatic mutations in the TP53 gene are present in up to 50% of patients with relapsed or refractory chronic lymphocytic leukemia. This study aims to review and compare the methods used to detect somatic TP53 mutations and/or 17p deletions and analyze their importance in the chronic lymphocytic leukemia diagnosis and follow-up. In chronic lymphocytic leukemia patients with refractory or recurrent disease, the probability of clonal expansion of cells with the TP53 mutation and/or 17p deletion is very high. The studies assessed showed several methodologies able to detect these changes. For the 17p deletion, the chromosome G-banding (karyotype) and interphase fluorescence in situ hybridization are the most sensitive. For somatic mutations involving the TP53 gene, moderate or high-coverage read next-generation sequencing and Sanger sequencing are the most recommended ones. The TP53 gene mutations represent a strong adverse prognostic factor for patient survival and treatment resistance in chronic lymphocytic leukemia. Patients carrying low-proportion TP53 mutation (less than 20-25% of all alleles) remain a challenge to these tests. Thus, for any of the methods employed, it is essential that the laboratory conduct its analytical validation, documenting its accuracy, precision and sensitivity/limit of detection.
Asunto(s)


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: LILACS Asunto principal: Leucemia Linfocítica Crónica de Células B / Genes p53 / Deleción Cromosómica / Mutación Tipo de estudio: Estudio diagnóstico / Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: Hematol., Transfus. Cell Ther. (Impr.) Asunto de la revista: Hematologia / TransfusÆo de Sangue Año: 2020 Tipo del documento: Artículo País de afiliación: Brasil Institución/País de afiliación: Grupo Fleury/BR / Hemocentro/BR / Instituto Nacional do Cancer - INCA/BR / Universidade de São Paulo - USP/BR

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: LILACS Asunto principal: Leucemia Linfocítica Crónica de Células B / Genes p53 / Deleción Cromosómica / Mutación Tipo de estudio: Estudio diagnóstico / Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: Hematol., Transfus. Cell Ther. (Impr.) Asunto de la revista: Hematologia / TransfusÆo de Sangue Año: 2020 Tipo del documento: Artículo País de afiliación: Brasil Institución/País de afiliación: Grupo Fleury/BR / Hemocentro/BR / Instituto Nacional do Cancer - INCA/BR / Universidade de São Paulo - USP/BR
...